Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and in situ intestinal perfusion

References

• Avdeef A. (2001). Physicochemical profiling (solubility, permeability and charge state). Curr Top Med Chem 1:277–351.
   PubMedGoogle Scholar
• Balimane PV, Chong S, Morrison RA. (2000). Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods 44:301–12.
   PubMed Web of Science ®Google Scholar
• Bareford LA, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748–58.
   PubMed Web of Science ®Google Scholar
• Culy CR, Jarvis B. (2001). Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus. Drugs 61:1625–60.
   PubMed Web of Science ®Google Scholar
• Davda J, Labhasetwar V. (2002). Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 233:51–9.
   PubMed Web of Science ®Google Scholar
• Deli MA. (2009). Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 1788:892–910.
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, et al. (1996). Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–45.
   PubMed Web of Science ®Google Scholar
• Dezani TM, Dezani AB, Coquemala da Silva MM, et al. (2017). In situ intestinal perfusion in rodents: future perspectives for application on absorption studies and classification of drugs. Mini Rev Med Chem 17:746–57.
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH II. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–73.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. (2009). Mechanisms of endocytosis. Annu Rev Biochem 78:857–902.
   PubMed Web of Science ®Google Scholar
• Donkor DA, Tang XS. (2014). Tube length and cell type-dependent cellular responses to ultra-short single-walled carbon nanotube. Biomaterials 35:3121–31.
   PubMed Web of Science ®Google Scholar
• Ebrahimi HA, Javadzadeh Y, Hamidi M, et al. (2015). Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles. Daru 23:46.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, Shehata EMM, Galal S, et al. (2017). Self-emulsifying preconcentrates of daidzein-phospholipid complex: design, in vitro and in vivo appraisal. Nanomedicine (Lond) 12:893–910.
   PubMed Web of Science ®Google Scholar
• Feng SS. (2004). Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices 1:115–25.
   PubMed Web of Science ®Google Scholar
• Gaba B, Fazil M, Ali A, et al. (2015). Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv 22:691–700.
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Altschuler Y, Benita S. (2008). Nanoparticle–cell interactions: drug delivery implications. Crit Rev Ther Drug Carrier Syst 25:485–544.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66:2873–96.
   PubMed Web of Science ®Google Scholar
• Hua S, Marks E, Schneider JJ, et al. (2015). Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine 11:1117–32.
   PubMed Web of Science ®Google Scholar
• Huehn D, Kantner K, Geidel C, et al. (2013). Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 7:3253–63.
   PubMed Web of Science ®Google Scholar
• Hwang SR, Byun Y. (2014). Advances in oral macromolecular drug delivery. Expert Opin Drug Deliv 11:1955–67.
   PubMed Web of Science ®Google Scholar
• Kou LF, Sun J, Zhai YL, et al. (2013). The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci 8:1–10.
   Google Scholar
• Lai SK, Wang Y-Y, Hanes J. (2009). Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–71.
   PubMed Web of Science ®Google Scholar
• Lerch S, Dass M, Musyanovych A, et al. (2013). Polymeric nanoparticles of different sizes overcome the cell membrane barrier. Eur J Pharm Biopharm 84:265–74.
   PubMed Web of Science ®Google Scholar
• Liu H, Ma Y, Liu D, et al. (2016). The effect of surfactant on paclitaxel nanocrystals: an in vitro and in vivo study. J Biomed Nanotechnol 12:147–53.
   PubMed Web of Science ®Google Scholar
• Lozoya-Agullo I, Zur M, Wolk O, et al. (2015). In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches. Int J Pharm 480:1–7.
   PubMed Web of Science ®Google Scholar
• Maruyama K. (2002). PEG-immunoliposome. Biosci Rep 22:251–66.
   PubMed Web of Science ®Google Scholar
• Mu S, Li M, Guo M, et al. (2016). Spironolactone nanocrystals for oral administration: different pharmacokinetic performances induced by stabilizers. Colloids Surf B Biointerf 147:73–80.
   PubMed Web of Science ®Google Scholar
• Niu Z, Conejos-Sanchez I, Griffin BT, et al. (2016). Lipid-based nanocarriers for oral peptide delivery. Adv Drug Deliv Rev 106:337–54.
   PubMed Web of Science ®Google Scholar
• Nkabinde LA, Shoba-Zikhali LNN, Semete-Makokotlela B, et al. (2014). Poly(d,l-lactide-co-glycolide) nanoparticles: uptake by epithelial cells and cytotoxicity. Express Polym Lett 8:197–206.
   Web of Science ®Google Scholar
• Pantarotto D, Briand JP, Prato M, et al. (2004). Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 40:16–7.
   PubMed Web of Science ®Google Scholar
• Pawar VK, Meher JG, Singh Y, et al. (2014). Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives. J Control Release 196:168–83.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang Z, Sun X, et al. (2010). Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm 7:565–75.
   PubMed Web of Science ®Google Scholar
• Rabanel JM, Aoun V, Elkin I, et al. (2012). Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. Curr Med Chem 19:3070–102.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. (2010). Endocytosis of nanomedicines. J Control Release 145:182–95.
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, et al. (2009). Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 17:249–56.
   PubMed Web of Science ®Google Scholar
• Shakweh M, Ponchel G, Fattal E. (2004). Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin Drug Deliv 1:141–63.
   PubMedGoogle Scholar
• Shan W, Zhu X, Liu M, et al. (2015). Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano 9:2345–56.
   PubMed Web of Science ®Google Scholar
• Shinde RL, Jindal AB, Devarajan PV. (2011). Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr Nanosci 7:119–33.
   Web of Science ®Google Scholar
• Soe Z, Poudel B, Nguyen H, et al. (2019). Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells. Asian J Pharm Sci 14:40–51.
   PubMed Web of Science ®Google Scholar
• Song Y, Chen L. (2015). Effect of net surface charge on physical properties of the cellulose nanoparticles and their efficacy for oral protein delivery. Carbohydr Polym 121:10–7.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Li L, et al. (2016). Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Colloids Surf B: Biointerfaces 143:47–55.
   PubMed Web of Science ®Google Scholar
• Sun M, Gao Y, Zhu Z, et al. (2017). A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity. Asian J Pharm Sci 12:51–8.
   PubMed Web of Science ®Google Scholar
• Xie S, Tao Y, Pan Y, et al. (2014). Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. J Control Release 187:101–17.
   PubMed Web of Science ®Google Scholar
• Yin L, Huang S, Zhu C, et al. (2012). In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm 38:1371–80.
   PubMed Web of Science ®Google Scholar
• Yoo J-W, Doshi N, Mitragotri S. (2011). Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev 63:1247–56.
   PubMed Web of Science ®Google Scholar
• Yu Y, Feng R, Li J, et al. (2019). A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform. Asian J Pharm Sci 14:423–34.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Barzegar-Jalali M, Tajerzadeh H, et al. (2005). Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J Pharm Biomed Anal 39:624–30.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Nasti A, Tirelli N. (2011). Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model. Macromol Biosci 11:1747–60.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu J, Zhang Q, et al. (2014). Enhanced cellular uptake and anti-proliferating effect of chitosan hydrochlorides modified genistein loaded NLC on human lens epithelial cells. Int J Pharm 471:118–26.
   PubMed Web of Science ®Google Scholar